Practical Approach to Managing SCIg Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Key Points

Individualized dosing strategies optimize treatment for chronic inflammatory demyelinating polyneuropathy.
Ongoing patient monitoring is essential for achieving better therapeutic outcomes with SCIg therapy.
Engaging patients in their treatment plan fosters better adherence and response to SCIg.
Practical guidance aids clinicians in making informed decisions regarding SCIg treatment choices.

Abstract

These patient cases provide practical guidance for SCIg therapy in CIDP maintenance, emphasizing individualized dosing strategies, ongoing monitoring, and patient-centered engagement. The findings help inform clinical decision-making to optimize long-term therapeutic outcomes.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Vu et al. (Tue,) studied this question.

synapsesocial.com/papers/69a75b46c6e9836116a2254f https://doi.org/https://doi.org/10.1002/mus.70151

Bookmark

View Full Paper